IGC Pharma (IGC) EBT Margin (2010 - 2025)
IGC Pharma (IGC) posted quarterly EBT Margin of 953.4% for Q3 2025, down 53666.0% year-over-year from N/an in Q3 2024, and down 95.57% quarter-over-quarter from 487.5% in Q2 2025.
IGC Pharma (IGC) EBT Margin (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported EBT Margin for 16 consecutive years, with 953.4% the latest figure, recorded in Q3 2025.
- In Q3 2025, EBT Margin fell 53666.0% year-over-year to 953.4%; the TTM figure through Sep 2025 stood at 582.91% (up 47956.0% YoY), while the FY2026 annual figure was 757.73%, down 19746.0% from the prior year.
- EBT Margin declined to 953.4% in Q3 2025 per IGC's latest filing, from 487.5% in the prior quarter.
- Across five years, EBT Margin topped out at 363.03% in Q1 2025 and bottomed at 7757.14% in Q3 2021.
- Historically, EBT Margin has averaged 1847.12% across 5 years, with a median of 977.97% in 2024.
- On a YoY basis, EBT Margin climbed as much as 723512 bps in 2021 and fell as far as 643154 bps in 2021.
- IGC Pharma's EBT Margin stood at 1676.76% in 2021, then soared by 60 bps to 677.41% in 2022, then tumbled by 304 bps to 2739.71% in 2023, then jumped by 74 bps to 711.67% in 2024, then sank by 34 bps to 953.4% in 2025.
- Business Quant data shows IGC's EBT Margin at 953.4% in Q3 2025, 487.5% in Q2 2025, and 363.03% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -953.40% |
| Jun 30, 2025 | -487.50% |
| Mar 31, 2025 | -363.03% |
| Dec 31, 2024 | -711.67% |
| Sep 30, 2024 | -416.75% |
| Jun 30, 2024 | -874.26% |
| Mar 31, 2024 | -977.97% |
| Dec 31, 2023 | -2,739.71% |
| Sep 30, 2023 | -842.27% |
| Jun 30, 2023 | -373.87% |
| Mar 31, 2023 | -2,427.71% |
| Dec 31, 2022 | -677.41% |
| Sep 30, 2022 | -1,208.91% |
| Jun 30, 2022 | -1,313.68% |
| Mar 31, 2022 | -5,330.33% |
| Dec 31, 2021 | -1,676.76% |
| Sep 30, 2021 | -7,757.14% |
| Jun 30, 2021 | -2,322.08% |
| Mar 31, 2021 | -3,640.74% |
| Dec 31, 2020 | -2,150.93% |